Evidence map›Paper›PMID 40366737›Full record

ArticleBioinformatics (Oxford, England)2025

Predicting ustekinumab treatment response in Crohn's disease using pre-treatment biopsy images.

Chengfei Cai, Ruidong Chen, Jieyu Chen, Jun Li, Caiyun Lv, Yiping Jiao, Lanqing Wu, Juan Chen, Qi Sun, Qianyun Shi and 3 more

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Chengfei CaiJiangsu Key Laboratory of Intelligent Medical Image Computing, School of Artificial Intelligence, Nanjing University of Information Science and Technology, Nanjing 210044, China.ORCID 0000-0002-9582-0348
Ruidong ChenDepartment of Gastroenterology, the Second Affiliated Hospital of Soochow University, Suzhou 215004, China.
Jieyu ChenDepartment of Pathology, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanjing 210008, China.
Jun LiJiangsu Key Laboratory of Intelligent Medical Image Computing, School of Artificial Intelligence, Nanjing University of Information Science and Technology, Nanjing 210044, China.
Caiyun LvDepartment of Gastroenterology, the Second Affiliated Hospital of Soochow University, Suzhou 215004, China.
Yiping JiaoJiangsu Key Laboratory of Intelligent Medical Image Computing, School of Artificial Intelligence, Nanjing University of Information Science and Technology, Nanjing 210044, China.ORCID 0000-0002-0787-3424
Lanqing WuDepartment of Pathology and Pathophysiology, Medical College of Soochow University, Soochow University, Suzhou 215123, China.
Juan ChenDepartment of Pathology and Pathophysiology, Medical College of Soochow University, Soochow University, Suzhou 215123, China.
Qi SunDepartment of Pathology, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanjing 210008, China.
Qianyun ShiDepartment of Pathology, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanjing 210008, China.
Jun XuJiangsu Key Laboratory of Intelligent Medical Image Computing, School of Artificial Intelligence, Nanjing University of Information Science and Technology, Nanjing 210044, China.
Wen TangDepartment of Gastroenterology, the Second Affiliated Hospital of Soochow University, Suzhou 215004, China.
Yao LiuDepartment of Gastroenterology, the Second Affiliated Hospital of Soochow University, Suzhou 215004, China.

Funding

National Key Research and Development Program of China 2023YFC3402800National Natural Science Foundation of China 62101365National Natural Science Foundation of China 62171230National Natural Science Foundation of China 62301263National Natural Science Foundation of China 62301265National Natural Science Foundation of China 62302228National Natural Science Foundation of China 62401272National Natural Science Foundation of China 82302291National Natural Science Foundation of China 82302352National Natural Science Foundation of China 82441029National Natural Science Foundation of China 92159301
6 · The paper itself

Abstract

motivationCrohn's disease (CD) exhibits substantial variability in response to biological therapies such as ustekinumab (UST), a monoclonal antibody targeting interleukin-12/23. However, predicting individual treatment responses remains difficult due to the lack of reliable histopathological biomarkers and the morphological complexity of tissue. While recent deep learning methods have leveraged whole-slide images (WSIs), most lack effective mechanisms for selecting relevant regions and integrating patch-level evidence into robust patient-level predictions. Therefore, a framework that captures local histological cues and global tissue context is needed to improve prediction performance.

resultsWe propose a novel clustering-enhanced weakly supervised learning framework to predict UST treatment response from pre-treatment WSIs of CD patients. First, patches from WSIs were encoded using a pre-trained vision foundation model, and k-means clustering was applied to identify representative morphological patterns. Discriminative patches associated with treatment outcomes were selected via a DenseNet-based classifier, with Grad-CAM used to enhance interpretability. To aggregate patch-level predictions, we adopted a multi-instance learning approach, from which whole-slide features were extracted using both patch likelihood histograms and bag-of-words representations. These features were subsequently used to train a classifier for final response prediction. Experimental results on an independent test set demonstrated that our WSI-level model achieved superior predictive performance with an AUC of 0.938 (95% CI: 0.879-0.996), sensitivity of 0.951, and specificity of 0.825, outperforming baseline patch-level models. These findings suggest that our method enables accurate, interpretable, and scalable prediction of biological therapy response in CD, potentially supporting personalized treatment strategies in clinical settings. AVAILABILITY AND IMPLEMENTATION: https://github.com/caicai2526/USTAIM.

Indexed as

Crohn DiseaseUstekinumabBiopsyDeep LearningHumansTreatment OutcomeUstekinumab

Identifiers

PMID40366737
PMCPMC12133262

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.